McKesson (NYSE:MCK) Hits New 12-Month High – Here’s What Happened

McKesson Corporation (NYSE:MCK)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $971.93 and last traded at $965.3830, with a volume of 48585 shares changing hands. The stock had previously closed at $963.24.

Analysts Set New Price Targets

Several equities research analysts have commented on MCK shares. Wells Fargo & Company raised their price target on shares of McKesson from $914.00 to $925.00 and gave the company an “equal weight” rating in a research note on Thursday, February 5th. JPMorgan Chase & Co. raised their target price on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Barclays increased their target price on shares of McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a research report on Wednesday, February 18th. Mizuho boosted their price target on shares of McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a report on Thursday, February 5th. Thirteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $943.50.

McKesson Stock Up 1.0%

The firm’s 50-day moving average price is $862.22 and its two-hundred day moving average price is $802.17. The firm has a market capitalization of $119.17 billion, a PE ratio of 27.95, a P/E/G ratio of 1.54 and a beta of 0.40.

McKesson (NYSE:MCK) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $9.34 EPS for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. The business had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. McKesson had a negative return on equity of 338.97% and a net margin of 1.09%.The firm’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the previous year, the company posted $8.03 earnings per share. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Equities research analysts forecast that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. McKesson’s payout ratio is presently 9.43%.

Insider Transactions at McKesson

In other news, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the stock in a transaction that occurred on Friday, February 6th. The shares were sold at an average price of $955.00, for a total transaction of $313,240.00. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Thomas L. Rodgers sold 276 shares of the business’s stock in a transaction dated Monday, January 5th. The shares were sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 1,143 shares of company stock valued at $1,046,070. Company insiders own 0.08% of the company’s stock.

Institutional Trading of McKesson

Large investors have recently bought and sold shares of the business. Brighton Jones LLC lifted its holdings in shares of McKesson by 46.3% in the fourth quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock valued at $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP bought a new position in shares of McKesson during the first quarter worth about $233,000. Sivia Capital Partners LLC raised its position in McKesson by 77.9% in the 2nd quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after buying an additional 300 shares during the last quarter. Transcend Capital Advisors LLC lifted its stake in McKesson by 12.3% in the 2nd quarter. Transcend Capital Advisors LLC now owns 1,304 shares of the company’s stock valued at $956,000 after acquiring an additional 143 shares in the last quarter. Finally, SYM FINANCIAL Corp acquired a new position in McKesson during the 2nd quarter worth approximately $228,000. 85.07% of the stock is owned by institutional investors.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.